About Exagen Inc.
For more information, please visit Exagen.com and follow @ExagenInc on Twitter.
Investor Relations
rdouglas@exagen.com
760.560.1525
Company
kadawi@exagen.com
![](https://ml.globenewswire.com/media/ZDY2NjAxMmYtMmQ0Ny00MWU4LWIwOGQtZjcyMDQ0NmFlOTBjLTEwMjI1NDU=/tiny/Exagen-Inc-.png)
2023 GlobeNewswire, Inc., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.815 USD | +0.28% |
|
-4.13% | -8.95% |
14/05 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
13/05 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
About Exagen Inc.
For more information, please visit Exagen.com and follow @ExagenInc on Twitter.
Investor Relations
rdouglas@exagen.com
760.560.1525
Company
kadawi@exagen.com
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-8.95% | 31.45M | |
+17.07% | 82.53B | |
-26.59% | 73B | |
-1.13% | 26.4B | |
-10.93% | 17.12B | |
+0.64% | 17.09B | |
-0.37% | 15.23B | |
+73.91% | 13.24B | |
+76.68% | 13.02B | |
-25.09% | 12.82B |